GAITHERSBURG, MD, RNAimmune announced today completion of its $2.35M seed round financing from multiple venture capitalists including Terra Magnum Capital Partners. Read More
WILMINGTON, DE, Prelude Therapeutics announced that it has completed a $50M Series C financing round led by OrbiMed Advisors and Fidelity Management & Research. Read More